Education and Training

  • August 24, 2016

    Ask The PCSS Expert: What Are Some Tips for Buprenorphine Treatment Inductions?

    A physician wrote the PCSS mentor network seeking advice about group inductions for buprenorphine/naloxone. The physician’s practice is starting a program with buprenorphine/ naloxone in primary care and says, “Due to space and time limitations we were considering doing group inductions with up to 5 patients, who then also would be enrolled in a ‘pain in recovery group’ of 8 weeks’ duration.”
  • May 11, 2016

    Ask the PCSS Expert: Is Sublingual Buprenorphine Safe to Use While Breastfeeding?

    Research shows drug exposure of infants is considered low. However, it is recommended that infants be monitored closely.
  • May 3, 2016

    ASAM Collaboration with Brandeis and Cigna Tests Addiction Treatment Performance Measures

    ASAM is working with Brandeis University to test and validate three performance measures related to addiction treatment using commercial administrative data from the health insurer Cigna. This follows a recent project testing performance measures using data from the Veterans Health Administration.
  • December 15, 2015

    Play a Role in the Future of Addiction Medicine

    The World Health Organization is requesting input from physicians, nurses, insurers, public health professionals and policy-makers on the ICD-11, the next version of the disease classification system used around the world. Of note to addiction clinicians are some reclassifications from the ICD-10 related to the relationships between impulse control disorders and behavioral addiction, such as pathological gambling, and substance use disorder.
  • December 15, 2015

    International Statement Recommending Against the Use of Terminology That Can Stigmatize People

    An editorial by Journal of Addiction Medicine Senior Editor, Dr. Richard Saitz, MPH, FACP, DFASAM, encourages the use of precise and non-stigmatizing terminology.
  • December 15, 2015

    Ask the PCSS Expert: Does Evidence Show Naltrexone Reduces Cravings?

    A physician wrote the PCSS mentor network seeking advice on naltrexone. They asked three questions.
  • October 9, 2015

    ASAM National Practice Guideline Stakeholder Summit Held

    More than ten medical societies, eight federal agencies and other patient and payer organizations met on September 24 to discuss strategies to help accelerate the adoption of ASAM's newly released National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.
  • October 9, 2015

    Ask the PCSS Expert: Fentanyl Patches and Induction?

    A physician wrote the PCSS mentor network seeking advice and recommendations on buprenorphine induction for patients on Fentanyl patches.
  • October 9, 2015

    Seattle’s LEAD Project – A Different Approach with Low-Level Drug Offenders

    Implemented on a pilot basis in Seattle, Washington in 2011, Law Enforcement Assisted Diversion (LEAD) was designed to finally truly integrate a public health approach into policing of street level drug use and sales (and concomitant behaviors such as street based sex work).
  • October 9, 2015

    CMS Issues 1115 Waiver Mentioning ASAM's Criteria

    Medicaid is playing an increasingly important role as a payer for services provided to individuals with addiction in the United States. There have been some exciting developments regarding The ASAM Criteria in Medicaid's expanding role......"exciting" for me anyway, because I have been on a mission for 25 years to have The ASAM Criteria accepted as the model for addiction treatment's continuum of care.
  • September 29, 2015

    2016 Ruth Fox Scholarship Open to Applicants

    The Ruth Fox scholarship program was started to encourage emerging physicians-in-training to pursue the addiction medicine field. It is important for ASAM to provide the education for these new physicians to identify and treat patients with addictive disorders because many medical schools do not include addiction medicine coursework or rotations.
  • September 24, 2015

    National Practice Guideline and Associated Products at Press Conference and Stakeholder Summit

    ASAM convened stakeholders, including several medical societies, eight federal agencies, patient and payers organizations at the National Press Club in Washington, DC, for a press conference and stakeholder summit to announce and accelerate the adoption of its newly released National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use (National Practice Guideline) and associated products.
  • September 10, 2015

    Increased marijuana, heroin use contribute to highest reported illicit drug use in more than a decade

    Findings from the 2014 National Survey on Drug Use and Health (NSDUH), released today, reveal the percentage of Americans aged 12 or older who used an illicit drug in 2014 was higher than in every year between 2002 and 2013, driven primarily by increases in marijuana use, sustained rates of nonmedical pain reliever use, and increases in heroin use.
  • August 14, 2015

    Brain Stimulation as a Potential Treatment for Addiction

    Brain stimulation has been in use for decades as a potential treatment for psychiatric disorders. However, its use in addiction is relatively new.
  • August 13, 2015

    Ask the PCSS Expert: Counseling Requirements in Addiction Treatment?

    A physician wrote the PCSS mentor network seeking advice on what type of counseling (group/individual/AA, NA/therapist) are typically required as part of addiction treatment.